Figure 1. Structural Formula Of Insulin Aspart-xjhz (Image 01)
Kirsty Injection, Solution
Product Images NDC 83257-007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Kirsty (NDC 83257-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2. Serial Mean Serum Glucose Collected Up To 6 Hours Following A Single 0.15 Units/kg Pre-meal Dose Of Insulin Aspart (solid Curve) Or Regular Human Insulin (hatched Curve) Injected Immediately Before A Meal In 22 Patients With Type 1 Diabetes (Image 02)
Figure 4 (Image 03)
Instructions For Use Prefilled Pen (Image 04)
Not available.*
Image-5 Instructions For Use Vial (Image 05)
Image-6: Instructions For Use Dose Vial (Image 06)
Image-7: Instructions For Use Vial Figures A And B (Image 07)
Image-8: Instructions For Use Vial Figure C (Image 08)
Image-9:instructions For Use Vial Figure D (Image 09)
Image-10:instructions For Use Vial Figure E (Image 10)
Image-11:instructions For Use Vial Figures F And G (Image 11)
Image-12:instructions For Use Vial Figure H (Image 12)
Image-13:instructions For Use Vial Figure I (Image 13)
Image-14:instructions For Use Vial Figure J (Image 14)
Image-15:instructions For Use Vial Figure K (Image 15)
Image-16:instructions For Use Vial Figure L (Image 16)
Figure 3. Mean Blood Glucose Profiles Following Intravenous Infusion Of Insulin Aspart (hatched Curve) And Regular Human Insulin (solid Curve) In 16 Patients With Type 1 Diabetes. R Represents The Time Of Autonomic Reaction. (Image 17)
This is a set of mean blood glucose levels measured at different time points. The blood glucose levels are shown in milligrams per deciliter (mg/dL) and decrease from 180 to 54. The time axis indicates intervals of 10 minutes. Slashes on the profile indicate a change or jump on the time axis.*
Instructions For Use Prefilled Pen Ultra-fine (Image 18)
Instructions For Use Prefilled Pen Figure A (Image 19)
Instructions For Use Prefilled Pen Figure B (Image 20)
Instructions For Use Prefilled Pen Figure C (Image 21)
Instructions For Use Prefilled Pen Figure D (Image 22)
Instructions For Use Prefilled Pen Figure E (Image 23)
Instructions For Use Prefilled Pen Figure F (Image 24)
Instructions For Use Prefilled Pen Figure G (Image 25)
Instructions For Use Prefilled Pen Figure H (Image 26)
Instructions For Use Prefilled Pen Figure I (Image 27)
Instructions For Use Prefilled Pen Figure J (Image 28)
Instructions For Use Prefilled Pen Figure K (Image 29)
Image-33 (Image 33)
Image-34 (Image 34)
Image-35 (Image 35)
This text appears to be a medical description of a medication called "Kirsty- (insulin aspart-xjhz) injection" with a concentration of 100 units/mL (U-100). The medication is intended for subcutaneous use and is for single-patient use only. The packaging includes five prefilled pens. The text also mentions instructions for dispensing from a sealed carton. The medication is manufactured by Biocon Biologics. Additional details regarding lot number, expiration date, and serialization are provided on the packaging.*
Image-36 (Image 36)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
